Delivery Order SPE2DB24D3015-SPE2DB25FFZUG

Award Date 6/13/25
Potential Completion Date 6/16/25
Potential Value $1.4K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $2,752.87 firm fixed-price delivery order contract awarded to Amerisourcebergen Drug Corp by the Defense Logistics Agency (DLA) for the supply of CIPRO 5% SUSPENSION 100ML. The contract has an ultimate completion date of May 21, 2025. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, providing a comprehensive global pharmaceutical...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $1,515.98, is for the supply of CIPRO 10% SUSPENSION 100ML, a pharmaceutical product. The contract is a firm fixed-price delivery order with an ultimate completion date of August 27, 2024. Amerisourcebergen, through its Corporate Office Division, is the prime contractor for this award, which is...
This is a $3,744.58 Firm Fixed Price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of CIPRO 5% SUSPENSION 100ML, a pharmaceutical product, with a period of performance through May 13, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 held by AmerisourceBergen with the DLA Troop Support Medical, which provides a comprehensive range...
This is a delivery order issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office division. The order, valued at $2,037.35, is for CIPRO 5% SUSPENSION 100ML, a pharmaceutical product. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and DLA Troop Support Medical, which has a ceiling value of up to $999,999,999 and runs through December 2025. The contract is for delivering a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract, valued at $1,655.55, is a delivery order for the supply of CIPRO 10% SUSPENSION 100ML, a pharmaceutical product. The contract has an ultimate completion date of December 22, 2023 and is a firm fixed-price arrangement. Amerisourcebergen Drug Corp, a major pharmaceutical distributor, holds a significant Indefinite Delivery...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corporation, a major pharmaceutical and medical supply distributor. The contract is for the supply of CIPRO 5% Suspension 100ML, a pharmaceutical product. The contract has a firm fixed-price pricing type and a ceiling value of $2,981.34. The period of performance extends through September 18, 2024. This contract does not have a set-aside designation. AmerisourceBergen...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,182.33 firm fixed-price contract is for the supply of CIPRO 5% SUSPENSION 100ML, a pharmaceutical product. The delivery order is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, which provides a comprehensive global...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $1,313.33, is for the supply of CIPRO 5% SUSPENSION 100ML, a pharmaceutical product. The contract has an ultimate completion date of February 12, 2025 and is a firm fixed-price delivery order. The award does not indicate any set-aside requirements, suggesting open competition. Amerisourcebergen Drug Corp is the prime...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp Corporate Office Division. The contract is for the supply of CIPRO 5% SUSPENSION 100ML, a pharmaceutical product. The contract has a ceiling value of $3,406.75 and an ultimate completion date of August 28, 2024. The contract is a firm fixed-price delivery order, without a set-aside designation. Amerisourcebergen Drug Corp is a major supplier of pharmaceutical products and...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of CIPRO 5% SUSPENSION 100ML, a pharmaceutical product, with a ceiling value of $2,545.21. The contract has an ultimate completion date of September 6, 2024. Amerisourcebergen has been awarded multiple federal contracts and indefinite delivery contracts (IDCs) by various defense and civilian agencies, including the...
  • SPE2DB24D3015
    Indefinite Delivery Contract
  • SPE2DB24D3015-SPE2DB25FFZUG
    Delivery Order

This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of CIPRO 5% SUSPENSION 100ML. The contract has a ceiling value of $1,436.48 and a completion date of June 16, 2025. Amerisourcebergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which enables the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. This delivery order is not designated as a set-aside contract, indicating open competition. The contract aligns with the DLA's role in providing medical and pharmaceutical products to various government agencies, including the Defense Health Agency and U.S. Coast Guard.

Generated 9/12/25, 10:51 AM